| Myelodysplastic Syndrome |
1 |
1 |
| Biologic Therapy |
0 |
0.9 |
| Blood |
0 |
0.59 |
| Stem Cell Research and Therapy |
0 |
0.56 |
| Bone Marrow Transplant |
0 |
0.52 |
| Blood Transfusion |
0 |
0.5 |
| Acute Leukemia |
0 |
0.48 |
| Bone Marrow |
0 |
0.45 |
| Transplantation |
0 |
0.36 |
| Bone |
0 |
0.32 |
| Transfusion |
0 |
0.27 |
| Acute Myeloblastic Leukemia |
0 |
0.99 |
| Genomic Medicine |
0 |
0.25 |
| Toxicology |
0 |
0.25 |
| Leukemia |
0 |
0.23 |
| Cancer |
0 |
0.21 |
| Thrombocytopenia |
0 |
0.21 |
| Anemia |
0 |
0.18 |
| Healthcare and Medical Technology |
0 |
0.15 |
| Chemotherapy |
0 |
0.14 |
| New York |
0 |
0.14 |
| Arrhythmia |
0 |
0.13 |
| Platelet-Derived Growth Factor |
0 |
0.1 |
| Biopsy |
0 |
0.09 |
| Clinical Research |
0 |
0.09 |
| Hematology |
0 |
0.09 |
| Immunomodulator |
0 |
0.09 |
| Immunotherapy |
0 |
0.09 |
| Platelet Count |
0 |
0.09 |
| CAR-T |
0 |
0.08 |
| Myelofibrosis |
0 |
0.08 |
| Neutropenia |
0 |
0.08 |